Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

More articles from ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

  • You have access
    Hepatic Uptake of Synthetic Chlorogenic Acid Derivatives by the Organic Anion Transport Proteins
    Dietmar Schwab, Andreas W. Herling, Horst Hemmerle, Gerrit Schubert, Bruno Hagenbuch and Hans-Joerg Burger
    Journal of Pharmacology and Experimental Therapeutics January 2001, 296 (1) 91-98;
  • You have access
    Scopolamine Bioavailability in Combined Oral and Transdermal Delivery
    Zohar Nachum, Baruch Shahal, Avi Shupak, Orna Spitzer, Adi Gonen, Itzchak Beiran, Haim Lavon, Mirit Eynan, Shlomit Dachir and Aharon Levy
    Journal of Pharmacology and Experimental Therapeutics January 2001, 296 (1) 121-123;
  • You have access
    Enhanced Delivery of Doxorubicin into the Brain via a Peptide-Vector-Mediated Strategy: Saturation Kinetics and Specificity
    Christophe Rousselle, Maria Smirnova, Philippe Clair, Jeanne-Marie Lefauconnier, Alain Chavanieu, Bernard Calas, Jean-Michel Scherrmann and Jamal Temsamani
    Journal of Pharmacology and Experimental Therapeutics January 2001, 296 (1) 124-131;
  • You have access
    Influence of Antipsychotic, Antiemetic, and Ca2+Channel Blocker Drugs on the Cellular Accumulation of the Anticancer Drug Daunorubicin: P-glycoprotein Modulation
    Safaa Ibrahim, James Peggins, Alan Knapton, Thomas Licht and Adorjan Aszalos
    Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 1276-1283;
  • You have access
    Metabolism of Vitamin A and Its Active Metabolite All-trans-retinoic Acid in Small Intestinal Enterocytes
    Alfonso Lampen, Silke Meyer, Thomas Arnhold and Heinz Nau
    Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 979-985;
  • You have access
    Sequence Analyses of CYP2B Genes and Catalytic Profiles for P450s in Qdj:Sprague-Dawley Rats That Lack Response to the Phenobarbital-Mediated Induction of CYP2B2
    Hideyuki Yamada, Hiromi Matsunaga, Kazuhiro Tsuji, Sanae Matsumoto, Midori Yamamoto, Yuji Ishii, Curtis J. Omiecinski and Kazuta Oguri
    Journal of Pharmacology and Experimental Therapeutics December 2000, 295 (3) 986-993;
  • You have access
    Tasosartan, Enoltasosartan, and Angiotensin II Receptor Blockade: The Confounding Role of Protein Binding
    Marc P. Maillard, Julien Rossat, Hans-R. Brunner and Michel Burnier
    Journal of Pharmacology and Experimental Therapeutics November 2000, 295 (2) 649-654;
  • You have access
    Chronic Intragastric Infusion of Ethanol-Containing Diets Induces CYP3A9 While Decreasing CYP3A2 in Male Rats ,
    J. Craig Rowlands, Huamin Wang, Reza Hakkak, Martin J. J. Ronis, Henry W. Strobel and Thomas M. Badger
    Journal of Pharmacology and Experimental Therapeutics November 2000, 295 (2) 747-752;
  • You have access
    Scaling Drug Biotransformation Data from cDNA-Expressed Cytochrome P-450 to Human Liver: A Comparison of Relative Activity Factors and Human Liver Abundance in Studies of Mirtazapine Metabolism
    Elke Störmer, Lisa L. von Moltke and David J. Greenblatt
    Journal of Pharmacology and Experimental Therapeutics November 2000, 295 (2) 793-801;
  • You have access
    Right Heart Failure Impairs Hepatic Elimination of p-Nitrophenol without Inducing Changes in Content or Latency of Hepatic UDP-Glucuronosyltransferases
    Connie Y. Ng, Hany Ghabrial, Denis J. Morgan, Michael S. Ching, Richard A. Smallwood and Peter W. Angus
    Journal of Pharmacology and Experimental Therapeutics November 2000, 295 (2) 830-835;

Pages

  • Previous
  • Next
  • 1
  • …
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • …
  • 49
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics